Tandem Diabetes Care
TNDM
268 hedge funds and large institutions have $2.12B invested in Tandem Diabetes Care in 2023 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 84 increasing their positions, 86 reducing their positions, and 32 closing their positions.
134% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 32
47% more capital invested
Capital invested by funds: $1.45B → $2.12B (+$677M)
19% more funds holding
Funds holding: 226 → 268 (+42)
3.08% more ownership
Funds ownership: 106.93% → 110.01% (+3.1%)
2% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 86
27% less call options, than puts
Call options by funds: $13.2M | Put options by funds: $18.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$27M |
| 2 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$25.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.5M |
| 4 |
Morgan Stanley
New York
|
+$20.1M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$10.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$22.4M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$17.2M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$14.7M |
| 4 |
PIM
Paradice Investment Management
Denver,
Colorado
|
-$9.09M |
| 5 |
CC
Chicago Capital
Chicago,
Illinois
|
-$8.87M |
TNDM Hedge Fund Activity: Q4 2023 in Review
268 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q4 2023, worth a combined $2.12B — up 47% from $1.45B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new TNDM positions and 32 closed out — a net gain of 43 holders — while 84 added to existing stakes and 86 trimmed.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $27M. The largest seller was First Light Asset Management, cutting an estimated $22.4M.
- 268 institutional investors held Tandem Diabetes Care (TNDM) as of Q4 2023, up from 226 in Q3 2023.
- Funds reported $2.12B of Tandem Diabetes Care stock for Q4 2023, up 47% quarter-over-quarter.
- 75 funds opened new Tandem Diabetes Care positions in Q4 2023 and 32 closed out, a net change of +43 holders.
- The largest Tandem Diabetes Care buyer in Q4 2023 was ArrowMark Colorado Holdings, an estimated $27M added.
- The largest Tandem Diabetes Care seller in Q4 2023 was First Light Asset Management, an estimated $22.4M sold.
Based on aggregated 13F filings for Q4 2023.